Glaxo To Stop Paying Doctors To Promote Drugs
LINDA WERTHEIMER, HOST:
NPR's business news starts with new rules for Glaxo.
(SOUNDBITE OF MUSIC)
WERTHEIMER: The head of British - the British drug maker GlaxoSmithKline, told The New York Times yesterday that the company will stop paying doctors to promote its drugs. Pharmaceutical firms commonly pay physicians to speak at medical conferences - a practice criticized as a conflict of interest.
Glaxo's CEO told the company - told the paper - the company would also stop paying all its sales reps based on how many prescriptions doctors write.
NPR transcripts are created on a rush deadline by an NPR contractor. This text may not be in its final form and may be updated or revised in the future. Accuracy and availability may vary. The authoritative record of NPR’s programming is the audio record.